Venture
Bioventrix, Inc.
Latest Form D 2026-09-09- CIK 1283259
- State MA
- Other
- 25 Form D offerings since 2009-10-06
- Total sold
- $217M
- across 25 offerings
- Rounds
- 25
- Form D offerings since 2009-10-06
- Latest round
- $3M
- 2026-04-24 · 021-581767
- Investors
- 25
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2026-04-24 · $3M
- 2009-10-06$5.6M021-63644
- 2011-01-14$3.9M021-153748
- 2011-10-11$5.1M021-166994
- 2011-10-11$5.1M021-166996
- 2011-11-22$6M021-169130
- 2012-02-27$0021-174023
- 2012-03-07$330K021-174474
- 2012-04-23$5.1M021-177113
- 2012-11-21$4.5M021-187352
- 2013-04-19$6.5M021-195236
- 2013-12-13$2M021-207963
- 2014-02-06$12.4M021-211445
- 2014-12-19$14M021-230553
- 2016-07-26$14.5M021-267692
- 2017-08-30$40M021-293763
- 2019-07-26$2.5M021-345144
- 2020-01-06$14.8M021-357195
- 2020-12-23$40.8M021-384132
- 2022-01-11$6M021-428786
- 2022-04-06$1M021-440668
- 2023-01-25$2M021-471718
- 2023-04-04$12.7M021-477788
- 2024-03-29$3M021-509158
- 2024-10-15$6.7M021-526850
- 2026-04-24$3M021-581767
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($40.8M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-581767 | First filed2026-04-24 | Latest2026-09-09 | Sought$10M | Sold$3M | Investors25 | Exemptions506(b) |
| 021-526850 | First filed2024-10-15 | Latest2025-11-04 | Sought$12M | Sold$6.7M | Investors45 | Exemptions506(b) |
| 021-509158 | First filed2024-03-29 | Latest2024-08-29 | Sought$3M | Sold$3M | Investors21 | Exemptions506(b) |
| 021-477788 | First filed2023-04-04 | Latest2023-04-04 | Sought$15.7M | Sold$12.7M | Investors12 | Exemptions506(b) |
| 021-471718 | First filed2023-01-25 | Latest2023-01-25 | Sought$3M | Sold$2M | Investors18 | Exemptions506(b) |
| 021-440668 | First filed2022-04-06 | Latest2022-04-06 | Sought$10M | Sold$1M | Investors1 | Exemptions506(b) |
| 021-428786 | First filed2022-01-11 | Latest2022-01-11 | Sought$6M | Sold$6M | Investors5 | Exemptions506(b) |
| 021-384132 | First filed2020-12-23 | Latest2021-08-10 | Sought$45M | Sold$40.8M | Investors186 | Exemptions506(b) |
| 021-357195 | First filed2020-01-06 | Latest2020-11-25 | Sought$25M | Sold$14.8M | Investors108 | Exemptions506(b) |
| 021-345144 | First filed2019-07-26 | Latest2019-07-26 | Sought$3.9M | Sold$2.5M | Investors1 | Exemptions506(b) |
| 021-293763 | First filed2017-08-30 | Latest2019-07-23 | Sought$40M | Sold$40M | Investors162 | Exemptions506(b) |
| 021-267692 | First filed2016-07-26 | Latest2017-07-03 | Sought$14.5M | Sold$14.5M | Investors152 | Exemptions506(b) |
| 021-230553 | First filed2014-12-19 | Latest2015-12-08 | Sought$17.5M | Sold$14M | Investors64 | Exemptions506(b) |
| 021-211445 | First filed2014-02-06 | Latest2014-07-08 | Sought$12.4M | Sold$12.4M | Investors195 | Exemptions506(b) |
| 021-207963 | First filed2013-12-13 | Latest2014-01-24 | Sought$2M | Sold$2M | Investors4 | Exemptions506(b) |
| 021-195236 | First filed2013-04-19 | Latest2013-07-12 | Sought$8M | Sold$6.5M | Investors115 | Exemptions506 |
| 021-187352 | First filed2012-11-21 | Latest2013-01-28 | Sought$4.5M | Sold$4.5M | Investors109 | Exemptions506 |
| 021-177113 | First filed2012-04-23 | Latest2012-05-11 | Sought$7M | Sold$5.1M | Investors88 | Exemptions506 |
| 021-174474 | First filed2012-03-07 | Latest2012-03-07 | Sought$6M | Sold$330K | Investors1 | Exemptions506 |
| 021-174023 | First filed2012-02-27 | Latest2012-02-27 | SoughtIndefinite | Sold$0 | Investors0 | Exemptions506 |
| 021-169130 | First filed2011-11-22 | Latest2011-11-22 | Sought$10M | Sold$6M | Investors146 | Exemptions506 |
| 021-166996 | First filed2011-10-11 | Latest2011-10-11 | Sought$10M | Sold$5.1M | Investors118 | Exemptions506 |
| 021-166994 | First filed2011-10-11 | Latest2011-10-11 | Sought$10M | Sold$5.1M | Investors118 | Exemptions506 |
| 021-153748 | First filed2011-01-14 | Latest2011-07-28 | Sought$10M | Sold$3.9M | Investors90 | Exemptions506 |
| 021-63644 | First filed2009-10-06 | Latest2010-12-16 | Sought$5.6M | Sold$5.6M | Investors157 | Exemptions506 |
Who backs Bioventrix, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-09-09
| Name | Relationship |
|---|---|
| David Richmond | RelationshipExecutive Officer, Director |
| Steven Chartier | RelationshipExecutive Officer, Director |
| Rishi Puri | RelationshipDirector |
| William T. Abraham | RelationshipDirector |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| Taglich Brothers, Inc. | CRD29102 | Broker-dealer— | Offerings13 |
| TAGLICH BROTHERS, INC. | CRD29102 | Broker-dealer— | Offerings5 |
| TAGLICH BROTHERS, INC. | CRD— | Broker-dealer— | Offerings1 |
| FREDERICK REICHENBACH | CRD5844798 | Broker-dealerTHIRD500, LLC · CRD 115542 | Offerings1 |
| RAY REYNA JR. | CRD3060626 | Broker-dealerTHE BENCHMARK COMPANY, LLC · CRD 22982 | Offerings1 |
| THOMAS C. ARMSTRONG | CRD5915163 | Broker-dealerFINALIS SECURITIES LLC · CRD 305908 | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Other
- State
- Massachusetts (MA)
- Exemptions
- Rule 506(b); Rule 506
- First filed
- 2009-10-06
- Latest filing
- 2026-09-09
Who backs Bioventrix, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗